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Molecular community profiling of 
the bacterial microbiota associated 
with denture-related stomatitis
Daniel J. Morse  1, Ann smith3, Melanie J. Wilson2, Lucy Marsh3, Lewis White4, 
Raquel posso4, David J. Bradshaw5, Xiaoqing Wei2, Michael A. o. Lewis2 & David W. Williams2
Denture-associated stomatitis (DS) affects over two-thirds of denture-wearers. DS presents as 
erythema of the palatal mucosa in areas where denture-surface associated polymicrobial biofilms 
containing the fungus Candida albicans exist. The contribution of the oral bacterial microbiota toward 
the infection is unknown. Therefore, this study characterised the bacterial microbiota of sites within 
the oral cavity to identify potential associations with occurrence of DS. Denture-wearing patients were 
recruited (denture stomatitis (Ds) n = 8; non-denture stomatitis (NoDS) n = 11) and the oral bacterial 
microbiota of the tongue, palate and denture-fitting surface was characterised using next-generation 
sequencing. Operational taxonomic units (OTUs) were identified to bacterial genera and species, and 
presence/absence and relative abundances were examined. A significant (P = 0.007) decrease in the 
number of OTUs and thus, diversity of the microbiota was observed in tongue samples of DS patients 
(vs non-DS). The microbiota of denture-fitting surfaces and palatal mucosae were similar. Large 
differences in the abundance of bacterial genera and species were observed at each sample site, and 
unique presence/absence of bacteria was noted. Presence/absence and relative abundance of specific 
bacteria associated with DS warrants further in vitro and in vivo evaluation, particularly as our previous 
work has shown C. albicans virulence factor modulation by oral bacteria.
The microbiota of higher organisms, and particularly humans, are of great interest given their affiliation with 
homeostasis of the host and normal function of many different body sites. There is substantial interest in the onset 
of disease that may be attributed to the endogenous microbiota, fuelled by the view that whilst these communities 
exist naturally at sites in the human body without negative impact toward the host, changes in the composition of 
the microbiota can lead to dysbiosis and development of localised and systemic infection.
Microbial communities are crucial to the normal function of many different environments in the human 
body, such as the gastrointestinal tract1,2 where microbial communities contribute to food breakdown, providing 
nutrients to surrounding host cells, thus developing a mutually beneficial relationship between the host and the 
resident microbiota. However, this benefit is not always maintained. Factors including the use of antibiotics, or 
significant changes in diet can lead to altered proportions of microorganisms in the gut microbiota, leading to 
dysbiosis and potential infection3–5.
Dysbiosis also applies to the oral cavity, where even subtle changes can lead to disease. This is evident in dental 
caries and periodontal disease, where an increase in the proportion of known ‘keystone’ pathogens, including 
Streptococcus mutans or Porphyromonas gingivalis, leads to substantial destruction of enamel and surrounding 
tissue, respectively6–10.
Various microenvironments exist within the oral cavity, offering a number of unique surfaces for microbial 
colonisation e.g. hard tooth enamel surfaces and soft tissues. Each location supports a distinct microbiota, arising 
from, among other factors, the diverse environmental conditions, physical environment and nutrient availability. 
The resident oral microbiota can inhibit the development of diseases including dental caries11 by minimising lev-
els of potentially pathogenic microorganisms10,12, through direct competition for colonisation and/or nutrients13.
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Several studies have characterised the healthy bacterial microbiota at different sites in the oral cavity, including 
tooth surfaces, oral mucosae and saliva9,12,14, and The Human Oral Microbiome Database (HOMD), established 
in 2010, indicates that over 700 bacterial species exist in the mouth15.
In addition to bacteria within the oral microbiota, fungi play an increasingly acknowledged role in the onset 
of disease. Oral candidosis, for example, is one such frequently occurring, but somewhat underappreciated infec-
tion. Candida albicans remains the most frequent Candida species isolated from the oral cavity and is widely 
regarded as the primary cause of chronic erythematous candidosis (also known as denture-associated stomatitis; 
DS). DS affects approximately 67% of denture wearers16, presenting as erythema of the palatal mucosa in areas 
that are in direct contact with the fitting-surface of a complete or partial denture. The extent of inflammation can 
be categorised according to Newton’s classification17: Type 0, no erythema; Type 1, localised, pinpoint erythema; 
Type 2, diffuse erythema (moderately red, covering part or all of the area of denture contact); Type 3, hyperplastic 
granular inflammation (severely red or swollen palatal mucosa)18–20.
Although it is recognised that C. albicans is the primary causative microorganism of DS, several predisposing 
factors known to promote the condition have been documented including tobacco use, nocturnal denture wear-
ing, ill-fitting dentures, and poor oral and denture hygiene. However, our knowledge of the role of the bacterial 
microbiota and the contribution toward DS is poor.
C. albicans is described as an opportunistic pathogen, with the ability to exist in a commensal yeast-like form, 
and can undergo a morphogenic transition to elongated hyphae, considered the pathogenic form21. Previously, we 
have shown that biofilms containing oral bacteria and C. albicans result in significantly greater tissue damage and 
an increased immune response relative to C. albicans-only biofilms22,23. Furthermore, in these previous studies, C. 
albicans hyphae, and the expression of a range of virulence factors including hydrolytic enzymes, were shown to 
increase when C. albicans was cultured with oral bacteria in mixed-species biofilms. We have also found that the 
inclusion of other oral bacteria, albeit another keystone pathogen (Porphyromonas gingivalis), in mixed-species 
biofilms can further modulate the virulence of C. albicans, leading to reduced C. albicans virulence24.
As a result of these in vitro findings, the aim of this study was to characterise the bacterial microbiota at three 
oral sites (tongue, hard palate, and fitting-surface of the denture) in patients with and without clinical signs of DS, 
to further our understanding of the potential involvement of oral bacteria in DS.
Results
Patient demographics. A total of 19 patients were recruited to the study (denture stomatitis (DS) n = 8; 
non-denture stomatitis (NoDS) n = 11). The demographic and clinical data for the subjects are presented in 
Table 1. Samples were assigned an anonymised reference number (S001-S019). The sample ID included reference 
to the sample site; where T referred to tongue, P to palatal mucosa, and D was the denture-fitting surface (e.g. 
S001T, patient 1 tongue sample site).
More females (n = 11) were recruited than males (n = 8), and similar average ages 69.64 years (±13.84) and 
64.88 years (±7.14) were evident for both genders, respectively. Of the recruited patients, eight (42.1%) were 
current smokers.
Eight patients had DS to varying extent (Female n = 6; Male n = 2), whereas 11 individuals had no signs of DS 
(Female n = 5; Male n = 6).
Patient ID Gender Age (yrs)
Tobacco 
smoker
Denture stomatitis
Present
Newton’s 
Classification
S001 Female 59 Yes No 0
S002 Female 66 No Yes 1
S003 Male 66 No No 0
S004 Male 66 No No 0
S005 Male 52 Yes No 0
S006 Male 64 No No 0
S007 Female 67 No Yes 1
S008 Female 75 No No 0
S009 Male 72 Yes No 0
S010 Female 74 Yes Yes 2
S011 Female 36 Yes Yes 1
S012 Female 81 No No 0
S013 Male 75 Yes Yes 3
S014 Male 65 Yes Yes 2
S015 Female 72 No No 0
S016 Female 90 No Yes 2
S017 Male 59 No No 0
S018 Female 77 No No 0
S019 Female 69 Yes Yes 2
Table 1. Patient demographics recorded at recruitment for each individual patient (anonymised).
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Detection of Candida species by culture and pCR. Detection of Candida is detailed in Table 2. Patients 
that were positive for Candida by either agar culture or nested PCR were included in the bacterial community 
profiling analysis.
Several samples that did not yield Candida growth by agar culture did test positive for Candida by the nested 
PCR method. These samples were S003D, S006P, S006D, S007T, S007D, S008T, S008P, S013D, S014P, S015D. In 
these sample descriptions, D, P and T represent denture, palate and tongue, respectively. Conversely, Candida was 
not detected by molecular testing of the S014T sample but was detected by culture.
From each sample type (i.e. tongue, palate or denture) on SDA, several typical colonies were subcultured on to 
CHROMagar® Candida agar. The agar plates were incubated for 48 h, after which, a turquoise/green colour was 
observed for colonies, indicating presumptive identification of C. albicans.
Nested real-time PCR was used to identify Candida in samples to species level. Amplicons were observed 
in the pan-Candida channel for numerous samples, but no detection was evident in the C. glabrata or C. krusei 
probe channels, thus eliminating the presence of these species. These results, when considered alongside those 
of culture, indicated the presence of Candida, presumably C. albicans, in all tested samples, and subsequent germ 
tube tests confirmed the ability of isolates  to form hyphae in the presence of serum.
Metataxonomic profiling of bacterial species present in swab samples. Of the 57 samples col-
lected, 55 were processed for DNA sequencing. Five failed to yield amplicons in the primary stage, thus the 
remaining 50 samples were used in subsequent analyses. A total of 2,194,967 sequence reads were obtained, and 
after quality control steps, the total number of final reads was 1,864,575. To normalise between samples, the OTUs 
were sub-sampled to the lowest read count (S019P) of 10,995 reads.
Patients were grouped by disease status i.e. presence or absence of clinical symptoms of DS (DS or NoDS, 
respectively), and analysed. In total, 2,411 OTUs were identified, 353 of which had more than ten sequence reads. 
Bacterial genera and species with ten or more sequence reads were included in analysis.
Duplicate bacterial species (which can arise due to strain sequence variation) when phylotypically classified 
were merged, along with their OTU and relative proportion data. Thus, the overall number of unique bacterial 
species was lower than the number of OTUs detected. Both were considered independently for the purpose of 
this study.
Differences in bacterial microbiota of DS and Non-DS patients. Quantities and relative proportions 
of bacterial genera were compared within sample sites (e.g. DS versus NoDS in samples of the tongue, palate and 
denture-fitting surface), and between sample sites, e.g. (Tongue DS versus Palate DS versus Denture DS). No 
significant (P > 0.05) differences were evident when comparing within or between sample sites for the number 
Patient 
ID
Candida presence Presumptive Candida 
species identification 
(CHROMagar/RT-PCR)
Tongue 
(Culture/PCR)
Palate 
(Culture/PCR)
Denture 
(Culture/PCR)
S001 +/NT +/NT +/NT C. albicans
S002 −/NT −/NT −/NT N/A
S003 −/− −/− −/+ Candida spp.
S004 +/+ +/+ −/+ C. albicans
S005 +/+ +/+ −/− C. albicans
S006 −/− −/+ −/+ Candida spp.
S007 −/+ −/− −/+ Candida spp.
S008 −/+ −/+ −/+ Candida spp.
S009 −/+ +/NT −/+ C. albicans
S010 −/+ −/+ +/NT C. albicans
S011 +/+ +/NT +/+ C. albicans
S012 +/+ +/NT +/+ C. albicans
S013 −/− −/− −/+ Candida spp.
S014 +/− −/+ +/NT C. albicans
S015 −/− −/− −/+ C. albicans
S016 −/− −/− −/− N/A
S017 −/− −/− −/− N/A
S018 −/− −/− −/− N/A
S019 +/NT +/NT +/NT C. albicans
Table 2. Candida presence and presumptive identification by culture and PCR. Candida presence (+) or 
absence (−) determined by positive agar culture and real-time PCR identification. Samples not tested by 
real-time PCR are denoted by NT. Samples that were positive by culture were further subcultured onto 
CHROMagar® Candida for presumptive identification of Candida species. N/A represents samples negative for 
detection of Candida by both culture and molecular analyses.
4Scientific RepoRts |         (2019) 9:10228  | https://doi.org/10.1038/s41598-019-46494-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
of genera when considering patients grouped by disease state and sample site (Fig. 1A). Similarly, no significant 
(P = 0.191) differences were evident when analysing patients grouped by disease status only (Fig. 1B).
The number of unique OTUs was determined for each sample (Chao index) (Fig. 2). The number of unique 
OTUs in samples of the denture-fitting surface (Fig. 2A) showed no significant differences (P = 0.806) between 
DS and NoDS patients. Similarly, samples from the palatal mucosa (Fig. 2B) in the same patients showed a slight 
increase in the number of unique bacterial species for NoDS patients, but this was not statistically significant 
(P = 0.104). However, a significant (P = 0.007) increase in the number of unique bacterial species was observed in 
samples from the tongue (Fig. 2C) of NoDS compared with DS patients.
The Shannon index was calculated (Fig. 3) as an indication of OTU abundance and evenness of spread, to 
indicate diversity within the samples. No significant differences (P > 0.05) were observed between DS and NoDS 
patients for any sample site. This was indicative that the frequency of OTUs was more evenly distributed across 
the whole population, rather than clusters of higher relative abundance associated with a smaller group of specific 
bacterial species. A slightly higher Shannon index was observed for NoDS samples from the palatal mucosa than 
DS samples, indicating that differences in the evenness of distribution between the frequency of bacterial species 
may have been present, but the differences were subtle and not significant.
Communities of microorganisms can be grouped by overall similarities of the bacterial microbiota and pre-
sented graphically to show whether or not the clusters are distinct. Where clusters of samples overlap, they are 
deemed not dissimilar. Non-metric multidimensional scaling plots were generated for each sample site (Fig. 4). 
The spread of the data points and the trends indicated by the ellipses of the patient groupings of DS and NoDS 
patients overlapped considerably in this analysis for all sample sites. This indicated the bacterial microbiota as 
a whole were not considered distinct, but as such showed greater overall similarities between the healthy and 
disease states. The spread within the results indicated some variation between samples, and inherent variability 
between patients.
Presence and differences in relative abundance of bacteria analysed at genera and species level. 
Despite no differences in the genera-associated microbiota being evident when considered collectively (Fig. 5), 
when analysing relative abundance differences between DS and NoDS at each sample site, some striking dif-
ferences were detected. Data presented in Fig. 5 (with corresponding specific numerical proportions pre-
sented in Supplementary Tables S1–S3) demonstrate the proportion of each detected genera as a mean value 
of all the participants in that sample group, where many substantial differences were observed. In samples of 
the denture-fitting surface (Fig. 5A,B), a number of shifts were observed, particularly in the genera associated 
with the top 15 genera by mean abundance. In DS-associated samples, increases in the relative abundance of 
Figure 1. Scatter plot of number of unique bacterial genera grouped by (A) sample site and DS state, and (B) 
DS state only. The number of bacterial genera for each patient when grouped by both sample site and DS state, 
and by DS state only, showing spread and error bars represent standard deviation. Similar mean numbers of 
bacterial genera were evident across all groupings, with no statistically significant differences.
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Streptococcus, Pseudomonas, and Stenotrophomonas were evident, with decreases in the relative abundance of 
Actinomyces, Serratia, and Rhizobium.
Shifts in relative abundances of genera were also observed in samples of other sites, including large increases 
in relative abundances observed in Streptococcus, Masillia and Acinetobacter in samples of the palate (Fig. 5C,D), 
and Streptococcus and Enterococcus in samples of the tongue (Fig. 5E,F). Large decreases in genera including 
Serratia, Lactobacillus and Flavobacterium were evident in samples of the palate, and similarly, decreases in 
Serratia and Flavobacterium were observed in samples of the tongue.
When considering the microbiota at species level, the relative proportion of different bacterial species varied 
considerably between samples and patients (Fig. 6; Supplementary Tables S4–6). Overall, the top 25 bacterial 
species by average abundance accounted for more than 85% of the total abundance of bacterial species, and in the 
case of samples from the palatal mucosa of DS patients, accounted for 98% of the overall abundance.
Hundreds of unique bacterial species were detected in each of the samples. Many species were unique to either 
DS or NoDS patients and may contribute to the incidence of DS. However, of the bacterial species found in both 
DS and NoDS patients, some substantial differences in the relative abundance were detected (Fig. 6).
In samples of the denture-fitting surfaces of NoDS patients (Fig. 6A), the relative proportions of Acinetobacter 
johnsonii and Streptococcus mitis were nearly three-fold higher compared with DS patients, and proportions of 
Actinomyces odontolyticus were nearly six-fold higher. Additional differences were also observed, but to a lesser 
Figure 2. Box and whisker plot showing Chao index analysis for each sample site. Number of unique bacterial 
operational taxonomic units (OTUs) for patients with DS (blue) compared with patients without DS (red) in 
samples of the (A) denture-fitting surface, (B) palatal mucosa surface and (C) tongue. A significant (P = 0.007) 
reduction in the number of detected OTUs was observed in samples from the tongue of DS patients, but strong 
similarities in samples of the denture-fitting surface and the palate were observed.
Figure 3. Box and whisker plot showing Shannon index analysis for each sample site. The richness and 
evenness of spread related to abundance of bacterial operational taxonomic units (OTUs) from patients with DS 
(blue) compared with patients without DS (red) in samples of the (A) denture-fitting surface, (B) palatal mucosa 
surface and (C) tongue. A general increase in Shannon index of each sample site indicated higher diversity and 
more equal distribution of abundance in samples from patients without clinical presentation of DS compared 
with patients with DS.
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extent. These included a reduction in the presence of Pseudomonas putida, A. lwoffii, Lactobacillus salivarius and 
a slight decrease in A. lingnae in samples from NoDS patients. Furthermore, two of the three most abundant 
bacterial species in samples of the fitting surface of the denture were unique to the DS group. These included an 
unknown species within the genus Myroides, and Pseudomonas fluorescens, with relative abundances of approxi-
mately 8.5% and 7.2%, respectively. The presence of Myroides was not detected at any other sample site.
Further differences were observed for microbiota of the palatal mucosa (Fig. 6B). Pseudomonas fluorescens 
was the bacterial species with highest representation in DS patients, but was also detected in NoDS patients. 
There was, however, a substantial difference in the average relative abundance, with a decrease from 19.99% 
in DS patients to 2.34% in NoDS patients. This was the largest difference for all bacterial species, irrespective 
of sample site. Furthermore, a greater than six-fold increase in the proportion of Brevundimonas vesicularis in 
NoDS patients compared with DS patients was evident. Conversely, a reduction of S. oralis, Chrysobacterium spp., 
B. terrae and a slight decrease in A. johnsonii were observed in NoDS patients. As was also evident in samples of 
the fitting surface of dentures, a number of unique bacterial species were detected in the DS and NoDS groups.
Streptococcus salivarius was detected at the highest relative abundance from tongue samples (Fig. 6C). A small 
reduction was observed between DS and NoDS patients of approximately 3% (DS = 18.41%, NoDS = 15.37%), 
but the abundances were still higher than all other bacteria detected in either the tongue samples of DS or NoDS 
patients. Large differences were observed in the proportion of P. fluorescens between DS (12.48%) and NoDS 
(2.06%), and S. mitis (DS = 6.09%, NoDS = 11.18%). Smaller differences were observed with other bacterial spe-
cies common between DS and NoDS patients, but their proportional contribution to the microbiota was approx-
imately 2% or less, thus the extent of the differences were less clear.
When patients were sub-grouped by smoking status, some clear differences in OTU relative abundances 
were evident. Strong similarities in the numbers of OTUs detected from samples of the denture-fitting surface 
were evident between smokers and non-smokers, irrespective of DS state (Fig. 7A). In samples from biotic sites 
(Fig. 7B,C), however, smokers with DS had a much reduced quantity of OTUs detected than all other groups, 
significantly (P < 0.05 vs non-smokers with DS and non-smokers without DS, and P < 0.01 versus smokers with 
DS) so in samples from the tongue (Fig. 7C).
Discussion
This research represents the first clinical study using next generation sequencing to characterise 
denture-associated biofilms from patients with and without clinical presentation of DS, with a specific aim of 
characterisation to species level to associate presence/absence and abundance with incidence of disease. Previous 
studies have evaluated DS associated microbiota, but the data were only analysed to genus level25,26. Campos et al., 
(2008) completed a similar study to the one reported here, using pooled swab samples of DS versus NoDS patient 
groups, but also only reported data at genus level27.
Genus-level information is important, but it is also well documented that considerable differences exist 
between species of the same genera. In the oral context, S. salivarius and S. mutans are good examples of distinct 
species within the same genus, particularly in terms of virulence and pathogenicity. Streptococcus salivarius is 
considered a commensal bacterial species, not normally associated with oral infection, whereas S. mutans is a 
known pathogen, associated with the development of dental caries. Furthermore, a study by Kim et al., (2017) 
demonstrated inter-kingdom interactions between S. mutans and C. albicans, where the presence of C. albicans 
resulted in an increase in the formation of microcolonies and subsequent virulence of S. mutans28. Therefore, an 
increase in proportion and virulence of a particular bacterial species may lead to a worse overall prognosis, and 
needs to be considered within the wider context of the microbiota.
Figure 4. Nonmetric multidimensional scaling (NMDS) plots of denture-associated stomatitis (DS) versus 
non-DS (NoDS) groups. NMDS ordination technique analysis of samples within DS and NoDS groups for each 
sample site to identify distinct clusters of groupings. (A) Denture-fitting surface, (B) palatal mucosa surface and 
(C) tongue. Overlapping groupings of samples were observed, thus the overall bacterial microbiota were not 
distinct.
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NGS data did not show any significant (P > 0.05) differences in the overall bacterial microbiota between 
patients with or without DS for the denture-fitting surface, or palatal mucosa. Indeed, the results for these sam-
ples were similar for both the number of unique species detected (Chao index), and in the richness and evenness 
of spread (Shannon index). However, in samples from the tongue, a significant (P = 0.007) decrease was observed 
in the number of unique bacteria species in patients with DS, compared to those without DS. This is interesting 
because a reduction in biodiversity, resulting in a state of dysbiosis, can lead to development of more extreme 
local environments where microorganisms with more extreme tolerances can thrive. Such changes in environ-
mental conditions have been observed in the lung and the gut, and as a result of these changes, the onset of dys-
biosis occurs, leading to an exacerbation of susceptibility to infections and a reduction in function particularly 
in the strictly-managed environment of the lung29,30. Subsequently, the behaviour of these microorganisms, and 
Figure 5. Pie chart graphical representations showing mean relative abundances of bacterial genera at each 
sample site. Top 15 bacterial genera (by mean abundances) in samples of the denture-fitting surface from 
patients (A) with DS and (B) without DS, samples of the palate from patients (C) with DS and (D) without DS, 
and samples of the tongue from patients (E) with DS and (F) without DS.
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the way they utilise nutrients and contribute to the local environmental conditions can further damage the local 
environment, such as the host31,32.
When analysing individual bacterial species, some clear and clinically interesting differences were evident. 
The abundance of individual bacterial species within sample groups revealed some notable differences. For exam-
ple, in samples from the denture-fitting surface, a bacterial species within the genus Myroides (species unknown) 
was found exclusively in the DS sample group (at approximately 8.5% relative abundance). Myroides (specifically 
the species M. odoratimimus) have been implicated in soft tissue infections of immunocompetent patients33, and 
linked with cases of bacteraemia in diabetic patients34, which is also a risk-factor for DS. It is therefore possible 
that this microorganism in the DS group could contribute to palatal inflammation. Alternatively, the presence of 
bacteria could also contribute to the local microbial community (biofilms) residing on the denture surface, and 
the modulation of Candida virulence, thus indirectly promoting palatal inflammation.
Pseudomonas fluorescens was detected exclusively in the denture samples from DS patients with an abundance 
of approximately 7%. This species was however also detected in both DS and NoDS samples of the palate and 
tongue, indicating its presence was not necessarily by chance, but it had successfully colonised each of these sites. 
There were notable differences in the abundance of P. fluorescens between DS and NoDS from palate (DS = 20%, 
NoDS = 2.3%) and tongue (DS = 12.5%, NoDS = 2%) samples. At both biotic sites (palate and tongue), there 
was therefore a basal level of P. fluorescens presence of approximately 2% of the overall bacterial microbiota. It is 
unclear whether the change in the abundance was caused by DS, or that it was responsible for the onset of DS. DS 
is a very complex infection with many influencing factors, where no apparent single factor contributes solely to 
the incidence or development of the disease.
Figure 6. Average relative abundance of top 10 individual bacterial species common to both DS (blue) and 
NoDS (red) patient groups in samples of the (A) denture-fitting surface, (B) palate, and (C) tongue.
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In anticipation of future clinical studies, it would be of interest to obtain additional clinical information of 
each patient, beyond the smoking status and demographic details. Information such as presence of diabetes, HIV 
status, diet, previous episodes of oral candidosis, denture state (e.g. age of denture, physical condition, cleaning 
regime), and dental health (including number of remaining teeth and oral hygiene regime) could have been 
assessed. Each of these may influence the conditions in the mouth, and thus, the resident microbiota. Poor gly-
caemic control due to diabetes has been associated with increased susceptibility to DS, as have HIV infection, 
smoking and poor oral hygiene, and with this limited sample set, although it would have been difficult to make 
statistically valid associations, an indication of trends may have provided foundation for additional studies to 
evaluate these parameters.
The sample collection, extraction and utilisation of DNA provided detailed information of what bacteria were 
present, but not necessarily whether they were viable or metabolically active. This is an interesting area to con-
sider, as the mere physical presence of microorganisms, irrespective of viability can elicit an immune response to 
the physical cell surface  components such as mannans and β-d-(1,3)-glucans of Candida35,36, and lipopolysac-
charide or peptidoglycan of Gram-negative and Gram-positive bacterial cells respectively36,37. Viable bacteria, 
particularly pathogens, will arguably lead to a worse prognosis without intervention, but follow up studies would 
be required, and it would be of scientific value to establish a baseline microbiota, then monitor changes with 
incidence of disease.
Conclusions
Although differences in the overall bacterial microbiota between sample sites were evident, considerable differ-
ences between DS and non-DS patients were observed for microbiota of the tongue. The tongue is an important 
reservoir of microorganisms for the oral cavity and the oropharynx, and is known to harbour many anaero-
bic microorganisms. The reduction in biodiversity demonstrated in patients with DS suggested that dysbiosis 
may contribute to the onset of disease/infection, whereby the relative influence of bacterial species of higher 
Figure 7. Box and whisker lot showing Chao index analysis, with samples grouped by sample site, DS state 
and sub-grouped by smoking status. A significant reduction was observed in smokers with DS relative to non-
smokers with DS and non-smokers without DS (P < 0.05) and smokers without DS (P < 0.01) in samples of the 
tongue, but no significant differences were observed in samples of the denture-fitting surface. Samples of the 
palate showed a similar trend to that of the tongue, but with no statistical significance.
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abundance within the community is further enhanced. These findings, taken together with our previous research 
documenting the bacterial modulation of Candida virulence, support the need for further exploration of the bac-
terial microbiota associated with DS and the importance of characterisation of complex communities to species 
level.
Materials and Methods
ethical approval. Research ethics committee approval was obtained (Wales REC 1) with the following ref-
erence information: Study title: Denture acrylic biofilms: microbial composition, interactions and prevention; 
REC reference: 14/WA/0023; Protocol number: SPON 1265-13; IRAS project ID: 137108. Patients attending the 
University Dental Hospital, Cardiff and Vale University Health Board, for routine treatment were recruited fol-
lowing informed consent.
patient recruitment and sample collection. In order to achieve a robust consistency between recruited 
individuals, strict criteria were used to exclude factors that are known to substantially impact the oral microbi-
ome. Patients were required to be over the age of 18 years, able and willing to consent, and have a complete upper 
acrylic denture. Patients who had received antibiotics or antifungal drugs, used steroids (systemic or inhaler), 
immunosuppressant or investigational drugs, or participated in another clinical study in the 30 days prior to 
recruitment, were not eligible for recruitment to the study.
The clinical information recorded for each patient included: gender, age, smoking status, and the presence and 
extent of denture stomatitis according to Newton’s classification.
Clinical sampling. Samples were obtained by clinically qualified and trained dental professionals employed 
by the Cardiff University School of Dentistry. The dental professionals worked under the guidelines and regula-
tion of the General Dental Council, and sampling performed according to best practices.
Prior to any clinical intervention, the fitting-surface of the denture, the tongue and the hard palate were sam-
pled using separate sterile Transwab® Amies Charcoal swabs (Medical Wire and Equipment, Wiltshire, UK), 
where the swabs were rubbed across each site for 15 s.
Additionally, for detection and isolation of Candida, individual 2 cm2 sterile foam squares pre-soaked in phos-
phate buffered saline solution (PBS) were pressed against the denture fitting surface, tongue and hard palate for 
30 s. The squares were then placed directly onto a Sabouraud dextrose agar (SDA) plate in the clinic prior to 
immediate transfer to the laboratory for aerobic incubation for 24–48 h at 37 °C. Random representative colonies 
considered typical for Candida were subcultured onto CHROMagar® Candida (BD Biosciences, Oxford, UK), 
and incubated for a further 48 h.
Laboratory processing of swab samples. Prior to collection of clinical samples, validation of the 
sampling process involving testing charcoal swabs was performed. Swabs of in vitro biofilms cultured using 
Streptococcus sanguinis NCTC 7863 and Candida albicans ATCC 90028 were collected, and the DNA extracted 
using the ‘Gram-positive bacteria’ extraction protocol of the Gentra PureGene Bact/Yeast DNA extraction kit 
(Qiagen, USA) as detailed by the manufacturer. The extracted and purified DNA was then subjected to endpoint 
PCR amplification. Positive amplification was observed confirming the suitability of the method. The relative level 
of microorganisms within clinical samples was anticipated to be less than would be observed in in vitro biofilms, 
therefore nested-PCR for detection of Candida species was incorporated to enhance sensitivity of detection.
Under aseptic conditions, the swab tip was carefully separated from the stem and placed into a sterile bijou 
container containing 1 ml of PBS, then vortex mixed at 2,500 rev/min for 1 min. The supernatant was collected, 
thoroughly mixed and transferred to a sterile microcentrifuge tube and centrifuged for 2 min at 13,000 × g. The 
supernatant was discarded and 300 μL of sterile PBS added. The suspension was then homogenised by pipetting. 
Aliquots of the suspension were prepared for DNA extraction for bacterial and fungal molecular analyses.
Total microbial DNA extraction from clinical swab samples. Total bacterial DNA was extracted 
using the Gentra PureGene Bact/Yeast DNA extraction kit (Qiagen, USA) according to the Gram-positive bac-
teria extraction protocol provided by the manufacturer. Extracted DNA was stored at −20 °C prior to next gen-
eration sequencing.
In addition to culture, Candida presence was established by nested PCR. A portion of the swab sample was 
used for extraction of yeast DNA using the Gentra PureGene Bacteria/Yeast DNA extraction kit, according to the 
yeast/fungi extraction protocol.
Identification of Candida from clinical samples by nested PCR. Extracted fungal DNA was 
pre-amplified using a general nested PCR and the RenDX Fungiplex Amplification Kit (Renishaw Diagnostics 
Ltd, Glasgow, UK) in a final reaction volume of 50 μL. The method targets the region spanning positions 620–760 
on the fungal 18S rRNA gene. Each reaction mix contained 5 μL of 10 × PCR buffer, 1 μL MgCl2, 4 μL dNTPs, 
10 μL primer mix (final concentration 600 mM), 19.5 μL molecular grade water, 0.5 μL (2.5 U) Taq polymerase 
and 10 μL of the extracted DNA template. Target DNA was amplified using the following thermal cycling pro-
tocol: 95 °C for 15 min, followed by 45 cycles of 94 °C for 30 s, 58 °C for 30 s and 72 °C for 30 s. A final elongation 
step of 72 °C for 7 min was performed. Samples were held at 4 °C until required for the next stage of amplification.
Amplified samples were subjected to a second round of probe-based real-time PCR to amplify 18S ribosomal 
RNA (18S rRNA) sequences specific to pan Candida species, C. krusei and C. glabrata. The primers used are 
detailed in Supplementary Table S7.
DNA samples were amplified in the second round using LightCycler FastStart DNA Master HybProbe (Roche 
Diagnostics, Sussex, UK), and reactions contained 2.5 μL of hybridisation mix, 3 μL of MgCl2, 15 μL of nuclease 
free molecular biology grade water, 2.5 μL of primer/probe mix and 2 μL of template DNA. The preparations were 
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homogenised by brief vortex mixing. DNA was amplified using the following thermal cycling protocol: 95 °C for 
15 min, followed by 30 cycles of 95 °C for 15 s, then 58 °C for 30 s. Amplicons were detected using the following 
fluorescence probes FAM (green), JOE (yellow) and ROX (orange) for detection of pan-Candida species, C. gla-
brata and C. krusei, respectively.
Metataxonomic profiling of bacterial microbiota of clinical swab samples using the Illumina 
MiSeq two stage amplification protocol. Bacterial DNA was sequenced by Research and Testing 
Laboratories (RTL, Texas, USA) using an Illumina 2-step protocol as outlined below.
Primary stage amplification. The forward primer was constructed (5′-3′) with the Illumina i5 sequencing primer 
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAG) and the 28F primer (GAGTTTGATCNTGGCTCAG), 
and the reverse primer was constructed with (5′-3′) the Illumina i7 sequencing primer (GTCTCGTGGGCTCGG 
AGATGTGTATAAGAGACAG) and the 388R primer (TGCTGCCTCCCGTAGGAGT). This region spans the 
V1-V3 hypervariable regions of the bacterial 16S rRNA gene. Reactions were performed using ABI Veriti ther-
mocyclers (Applied Biosystems, California, USA) in a 25 μL final volume comprising 22 μL of Qiagen HotStar 
Taq master mix (Qiagen Inc. California, USA), 1 μL of each primer (5 μM) and 1 μL DNA template. The thermal 
cycling protocol was: 95 °C for 5 min, then 25 cycles of 94 °C for 30 s, 54 °C for 40 s, 72 °C for 1 min, followed by 
one final cycle of 72 °C for 10 min; the products were then held at 4 °C.
Second stage amplification. Products from the first stage amplification were added to a second PCR, based 
on qualitatively determined concentrations. Primers for the second PCR were designed based on the Illumina 
Nextera PCR primers and were as follows: Forward - AATGATACGGCGACCACCGAGATCTACAC[i5index]
TCGTCGGCAGCGTC and Reverse - CAAGCAGAAGACGGCATACGAGAT[i7index]GTCTCGTGGGCTCGG. 
The thermal cycling protocol for this second stage amplification was the same as the first but limited to 10 cycles.
Standardisation of PCR products for next-generation sequencing. Amplicons were initially visual-
ised using eGels (Life Technologies, New York, USA). Products were pooled at equimolar concentrations and 
each pool was size selected in two rounds using Agencourt AMPure XP (BeckmanCoulter, Indiana, USA) in a 0.7 
ratio for both rounds. Size selected pools were then quantified using the Qubit 2.0 fluorimeter (Life Technologies) 
and loaded on an Illumina MiSeq (Illumina, Inc., California, USA) 2 × 300 flow cell at 10 pM.
Data analysis. The 16S rRNA gene sequences generated were analysed using the open source bioinformat-
ics software package, Mothur v 1.36.138,39 using the MiSeq SOP Pipeline to analyse 50 samples. The sequence 
alignment was performed using the Silva bacterial database40 as the reference, and classification of sequences 
were undertaken using the RDP (Ribosomal Database Project) database reference sequence files and the Wang 
method41. The OTU taxonomies (phylum to genus) were determined using the RDP Classifier script, and at 
species-level taxonomies was determined using USEARCH42 at ≥97% similarity. The cohorts were normalised to 
the lowest read count in Mothur (n = 10995). Alpha and beta indices were calculated using Mothur and R-script. 
The Chao and Shannon indices were used as a measurement of alpha-diversity as it takes into account both spe-
cies richness and the evenness of abundance among the species present in a given sample.
Taxonomic profiles for each metadata group were analysed using the paired Mann-Whitney tests to iden-
tify taxa at significantly higher or lower abundance. To determine statistical differences, the Statistical Analysis 
of Metagenomic Profiles (STAMP) software package was used43. The p-values in STAMP was calculated using 
Welch’s t-test with multiple testing corrections applied using the Bonferroni false discovery rate. Non-metric 
multidimensional scaling (NMDS) was used to visualise differences in patients with (DS) and without (NoDS) 
clinical symptoms, using the weighted Unifrac distance matrices (generated by Mothur) in Vegan R package44. 
Adonis (Vegan) was used to calculate significant differences between cohorts and species, using p-value < 0.05.
To test the quality of the samples and the diversity of these samples, we used the Spearman rank correlation 
in R.
Quantitative community analysis of bacterial genera and species. After phylotypic assignment to 
bacterial genera and species, the absolute occurrence (number of sequence reads within subsampled sets) of the 
OTUs was transformed into relative occurrence for comparison with other samples.
Relative proportions of specific bacterial genera and species, expressed as a percentage of the overall commu-
nity, were compared within and between each sample site, to determine whether changes in the abundance of spe-
cific bacterial genera and/or species could be associated or correlated to the incidence of DS. Relative quantities 
of bacterial genera present were analysed statistically using a one-way analysis of variance, with a Tukey’s multiple 
comparisons test, at 95% confidence.
Data Availability
The datasets generated and/or analysed during the current study are available in the Cardiff University data cata-
logue, https://doi.org/10.17035/d.2018.0051571814.
References
 1. Turnbaugh, P. J. & Gordon, J. I. The core gut microbiome, energy balance and obesity. The Journal of Physiology 587, 4153–8 (2009).
 2. O’Brien, C. L., Allison, G. E., Grimpen, F. & Pavli, P. Impact of colonoscopy bowel preparation on intestinal microbiota. Plos One 8, 
1–10 (2013).
 3. Turnbaugh, P. J., Backhed, F., Fulton, L. & Gordon, J. I. Diet-induced obesity is linked to marked but reversible alterations in the 
mouse distal gut microbiome. Cell Host and Microbe 3, 213–223 (2008).
 4. David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2013).
 5. Carmody, R. N. et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host and Microbe 17, 72–84 (2015).
1 2Scientific RepoRts |         (2019) 9:10228  | https://doi.org/10.1038/s41598-019-46494-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
 6. Marsh, P. D. & Bradshaw, D. J. Dental plaque as a biofilm. Journal of Industrial Microbiology 15, 169–175 (1995).
 7. Jenkinson, H. F. Beyond the oral microbiome. Environmental Microbiology 13, 3077–3087 (2011).
 8. Zarco, M. F., Vess, T. J. & Ginsburg, G. S. The oral microbiome in health and disease and the potential impact on personalized dental 
medicine. Oral Diseases 18, 109–120 (2012).
 9. Palmer, R. J. Composition and development of oral bacterial communities. Periodontology 2000 64, 20–39 (2014).
 10. Kilian, M., Chapple, I. L. C. & Hannig, M. The oral microbiome – an update for oral healthcare professionals. British Dental Journal 
221, 657–666 (2016).
 11. Burne, R. A. & Marquis, R. E. Alkali production by oral bacteria and protection against dental caries. FEMS Microbiology Letters 
193, 1–6 (2000).
 12. Wade, W. G. The oral microbiome in health and disease. Pharmacological Research: the official journal of the Italian Pharmacological 
Society 69, 137–43 (2013).
 13. Buffie, C. G. & Pamer, E. G. Microbiota-mediated colonization resistance against intestinal pathogens. Nature Reviews. Immunology 
13, 790–801 (2013).
 14. Acharya, A. et al. Salivary microbiome in non-oral disease: A summary of evidence and commentary. Archives of Oral Biology 83, 
169–173 (2017).
 15. Dewhirst, F. et al. The human oral microbiome. Journal of Bacteriology 192, 5002–5017 (2010).
 16. Arendorf, T. M. & Walker, D. M. The prevalence and intra-oral distribution of Candida albicans in man. Archives of Oral Biology 25, 
1–10 (1980).
 17. Newton A. Denture sore mouth: A possible aetiology. British Dental Journal. 112, 357–60 (1962)
 18. Samaranayake, L. P., Cheung, L. K. & Samaranayake, Y. Candidiasis and other fungal diseases of the mouth. Dermatologic Therapy 
15, 251–269 (2002).
 19. Coco, B. J. et al. Mixed Candida albicans and Candida glabrata populations associated with the pathogenesis of denture stomatitis. 
Oral Microbiology and Immunology [Online] 23, 377–83 (2008).
 20. Dar-Odeh, N. S., Al-Beyari, M. & Abu-Hammad, O. A. The role of antifungal drugs in the management of stomatitis. The 
International Arabic Journal of Antimicrobial Agents 2, 1–5 (2012).
 21. Santana, I. L. et al. Dietary carbohydrates modulate Candida albicans biofilm development on the denture surface. PloS ONE 8, 
e64645 (2013).
 22. Cavalcanti, Y. W. et al. Virulence and pathogenicity of Candida albicans is enhanced in biofilms containing oral bacteria. Biofouling: 
Journal of The Bioadhesion and Biofilm Research 31, 27–38 (2015).
 23. Morse, D. J. et al. Denture-associated biofilm infection in three-dimensional oral mucosal tissue models. Journal of Medical 
Microbiology 67, 364–375 (2018).
 24. Morse, D. J. et al. Modulation of Candida albicans virulence in in vitro biofilms by oral bacteria. Letters in Applied Microbiology 
68(4), 337–343, https://doi.org/10.1111/lam.13145 (2019).
 25. O’Donnell, L. E. et al. The oral microbiome of denture wearers is influenced by levels of natural dentition. Plos ONE 10, e0137717 
(2015).
 26. Shi, B. et al. The denture-associated oral microbiome in health and stomatitis. mSphere 1, e00216–16 (2016).
 27. Campos, M. S., Marchini, L., Bernardes, L. A. S., Paulino, L. C. & Nobrega, F. G. Biofilm microbial communities of denture 
stomatitis. Oral Microbiology and Immunology 23, 419–24 (2008).
 28. Kim, D. et al. Candida albicans stimulates Streptococcus mutans microcolony development via cross-kingdom biofilm-derived 
metabolites. Scientific Reports 7, 41332 (2017).
 29. Marsland, B. J. & Gollwitzer, E. S. Host-microorganism interactions in lung diseases. Nature Reviews Immunology [Online] 14, 
827–835 (2014).
 30. Li, Q. et al. Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease. Journal of Clinical 
Gastroenterology 48, 513–23 (2014).
 31. Takahashi, N. Microbial ecosystem in the oral cavity: metabolic diversity in an ecological niche and its relationship with oral 
diseases. International Congress Series 1284, 103–112 (2005).
 32. Matsubara, V. H., Bandara, H. M. H. N., Mayer, M. P. A. & Samaranayake, L. P. Probiotics as antifungals in mucosal candidiasis. 
Clinical Infectious Diseases 62, 1143–1153 (2016).
 33. Maraki, S., Sarchianaki, E. & Barbagadakis, S. Myroides odoratimimus soft tissue infection in an immunocompetent child following 
a pig bite: case report and literature review. Brazilian Journal of Infectious Diseases 16, 390–392 (2012).
 34. Endicott-Yazdani, T. R., Dhiman, N., Benavides, R. & Spak, C. W. Myroides odoratimimus bacteremia in a diabetic patient. 
Proceedings (Baylor University. Medical Center) 28, 342–343 (2015).
 35. Gow, N. A. R. et al. Immune recognition of Candida albicans β-glucan by dectin-1. Journal of Infectious Diseases 196, 1565–1571 
(2007).
 36. Sukhithasri, V., Nisha, N., Biswas, L., Anil Kumar, V. & Biswas, R. Innate immune recognition of microbial cell wall components and 
microbial strategies to evade such recognitions. Microbiological Research 168, 396–406 (2013).
 37. McDonald, C., Inohara, N. & Nuñez, G. Peptidoglycan signaling in innate immunity and inflammatory disease. Journal of Biological 
Chemistry 280, 20177–20180 (2005).
 38. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and 
comparing microbial communities. Applied and Environmental Microbiology 75, 7537–7541 (2009).
 39. Kozich, J. J., Westcott, S. L., Baxter, N. T., Highlander, S. K. & Schloss, P. D. Development of a dual-index sequencing strategy and 
curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 79(17), 
5112–20, https://doi.org/10.1128/AEM.01043-13 (2013).
 40. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids 
Research. 41, 590–596, https://doi.org/10.1093/nar/gks1219 (2013).
 41. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive bayesian classifier for rapid assignment of rRNA sequences into the new 
bacterial taxonomy. Applied and Environmental Microbiology 73(16), 5261–5267, https://doi.org/10.1128/AEM.00062-07 (2007).
 42. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461 (2010).
 43. Parks, D. H. & Beiko, R. G. Identifying biologically relevant differences between metagenomic communities. Bioinformatics 26, 
715–721 (2010).
 44. Dixon, P. (2003). Computer program review VEGAN, a package of R functions for community ecology. Journal of Vegetation 
Science. 14, 927–930 (2003).
Acknowledgements
 We  express our  gratitude to Dr Jeff Wilson and Dr Helen Rogers for their assistance with patient recruitment; 
obtaining informed consent and collecting the clinical samples. The work was funded by an Engineering and 
Physical Sciences Research Council-GlaxoSmithKline case-award PhD studentship.
13Scientific RepoRts |         (2019) 9:10228  | https://doi.org/10.1038/s41598-019-46494-0
www.nature.com/scientificreportswww.nature.com/scientificreports/
Author Contributions
D.W., M.W., X.W., D.B. and M.L. conceptualised and designed the study, and D.W., M.W., M.L. obtained ethical 
approval. D.M. processed the clinical samples with contributions from L.M., R.P. and L.W. and D.M. and 
A.S. completed the data analysis. D.M., D.W. and M.W. interpreted the results. D.M. primarily authored the 
manuscript, and all authors contributed to the content, revision, completion and approval of the final manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-46494-0.
Competing Interests: This work was financially supported by an Engineering and Physical Sciences Research 
Council and GlaxoSmithKline Consumer Healthcare case-award PhD studentship, grant number EP/
L505390/1. The funders had no specific role in the conceptualisation, design, data collection or analysis, nor the 
decision to publish the work. Dr David Bradshaw is employed by GlaxoSmithKline Consumer Healthcare. No 
other personal or company-associated financial interests to declare. No non-financial competing interests to 
declare.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
